Core Scientific FY2025 EPS Forecast Reduced by Roth Capital

Core Scientific, Inc. (NASDAQ:CORZFree Report) – Research analysts at Roth Capital cut their FY2025 earnings estimates for Core Scientific in a note issued to investors on Tuesday, January 7th. Roth Capital analyst D. Aftahi now expects that the company will post earnings per share of ($0.30) for the year, down from their previous estimate of ($0.29). Roth Capital has a “Strong-Buy” rating on the stock. The consensus estimate for Core Scientific’s current full-year earnings is $0.50 per share. Roth Capital also issued estimates for Core Scientific’s Q4 2025 earnings at ($0.01) EPS and FY2026 earnings at $0.33 EPS.

CORZ has been the subject of several other research reports. Needham & Company LLC increased their price objective on shares of Core Scientific from $17.00 to $18.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. Jefferies Financial Group started coverage on shares of Core Scientific in a report on Monday, October 28th. They issued a “buy” rating and a $19.00 target price for the company. B. Riley lifted their price objective on shares of Core Scientific from $16.00 to $17.00 and gave the company a “buy” rating in a report on Thursday, November 7th. HC Wainwright lifted their price objective on shares of Core Scientific from $15.00 to $17.00 and gave the company a “buy” rating in a report on Thursday, November 7th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $20.00 target price on shares of Core Scientific in a research report on Thursday, October 3rd. Thirteen analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $18.46.

Get Our Latest Report on CORZ

Core Scientific Stock Down 0.5 %

CORZ stock opened at $14.05 on Thursday. Core Scientific has a 52 week low of $2.61 and a 52 week high of $18.63. The company has a fifty day simple moving average of $15.62 and a two-hundred day simple moving average of $12.56. The firm has a market capitalization of $3.92 billion and a P/E ratio of -2.60.

Institutional Trading of Core Scientific

Several institutional investors and hedge funds have recently bought and sold shares of the business. Rise Advisors LLC lifted its stake in Core Scientific by 14.3% during the 3rd quarter. Rise Advisors LLC now owns 8,000 shares of the company’s stock valued at $95,000 after acquiring an additional 1,000 shares during the period. Sunbelt Securities Inc. acquired a new position in shares of Core Scientific in the 2nd quarter valued at $33,000. Vontobel Holding Ltd. boosted its holdings in Core Scientific by 10.4% during the third quarter. Vontobel Holding Ltd. now owns 38,089 shares of the company’s stock worth $452,000 after buying an additional 3,591 shares in the last quarter. Harvest Portfolios Group Inc. boosted its holdings in Core Scientific by 10.1% during the third quarter. Harvest Portfolios Group Inc. now owns 55,881 shares of the company’s stock worth $663,000 after buying an additional 5,109 shares in the last quarter. Finally, Pekin Hardy Strauss Inc. boosted its holdings in Core Scientific by 25.4% during the third quarter. Pekin Hardy Strauss Inc. now owns 30,725 shares of the company’s stock worth $364,000 after buying an additional 6,225 shares in the last quarter.

Insider Transactions at Core Scientific

In other Core Scientific news, CEO Adam Taylor Sullivan sold 88,380 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $14.24, for a total transaction of $1,258,531.20. Following the sale, the chief executive officer now owns 4,128,505 shares of the company’s stock, valued at approximately $58,789,911.20. The trade was a 2.10 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Yadin Rozov sold 105,000 shares of Core Scientific stock in a transaction that occurred on Friday, November 22nd. The shares were sold at an average price of $18.11, for a total transaction of $1,901,550.00. Following the sale, the director now owns 345,239 shares of the company’s stock, valued at approximately $6,252,278.29. The trade was a 23.32 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 348,241 shares of company stock valued at $5,436,802 in the last 90 days. Insiders own 32.00% of the company’s stock.

Core Scientific Company Profile

(Get Free Report)

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.

See Also

Earnings History and Estimates for Core Scientific (NASDAQ:CORZ)

Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.